Infectious Diseases

The FDA has approved Audenz (influenza A [H5N1] monovalent vaccine; Seqirus) for active immunization for the prevention of disease in patients 6 months of age and older at increased risk of exposure to the influenza A H5N1 virus subtype contained in the vaccine.